Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
14.37
+0.14 (0.98%)
May 12, 2026, 11:29 AM EDT - Market open
Janux Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Buy
Price Target
$45.08
Upside
+213.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $26 | Buy | Maintains | $30 → $26 | +80.93% | May 8, 2026 |
| Wedbush | Wedbush | Buy Maintains $45 → $36 | Buy | Maintains | $45 → $36 | +150.52% | May 8, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $68 → $58 | Strong Buy | Maintains | $68 → $58 | +303.62% | May 8, 2026 |
| Jones Trading | Jones Trading | Strong Buy Maintains $50 → $28 | Strong Buy | Maintains | $50 → $28 | +94.85% | Apr 28, 2026 |
| Barclays | Barclays | Buy → Sell Downgrades $29 → $14 | Buy → Sell | Downgrades | $29 → $14 | -2.57% | Apr 20, 2026 |
| UBS | UBS | Strong Buy → Hold Downgrades $57 → $15 | Strong Buy → Hold | Downgrades | $57 → $15 | +4.38% | Apr 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $150 → $100 | Buy | Maintains | $150 → $100 | +595.89% | Feb 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $72 → $68 | Strong Buy | Maintains | $72 → $68 | +373.21% | Feb 27, 2026 |
| Clear Street | Clear Street | Strong Buy → Hold Downgrades $32 → $12 | Strong Buy → Hold | Downgrades | $32 → $12 | -16.49% | Jan 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $30 | Buy | Maintains | $42 → $30 | +108.77% | Jan 16, 2026 |
| Barclays | Barclays | Buy Maintains $48 → $29 | Buy | Maintains | $48 → $29 | +101.81% | Dec 17, 2025 |
| Stifel | Stifel | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +164.44% | Dec 2, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $80 → $32 | Strong Buy | Maintains | $80 → $32 | +122.69% | Dec 2, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $58 → $49 | Strong Buy | Maintains | $58 → $49 | +240.99% | Dec 2, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $200 → $150 | Buy | Maintains | $200 → $150 | +943.84% | Dec 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $70 → $45 | Strong Buy | Maintains | $70 → $45 | +213.15% | Dec 2, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.